GENZYME CRITICIZED FOR ANORMED BID

Genzyme Corp. is under fire from AnorMed Inc. shareholders. Last month, Cambridge, Mass.-based Genzyme made an unsolicited offer to purchase AnorMed, a Canadian developer of cancer and AIDS treatments.
Boston Business Journal